Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
6.77M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
8.95M
-
Shares change
-
+144K
-
Total reported value, excl. options
-
$13.7M
-
Value change
-
+$213K
-
Put/Call ratio
-
0.02
-
Number of buys
-
12
-
Number of sells
-
-17
-
Price
-
$1.53
Significant Holders of DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) as of Q1 2024
42 filings reported holding DRIO - DarioHealth Corp. - Common Stock, par value $0.0001 per share as of Q1 2024.
DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.95M shares
.
Largest 10 shareholders include Nantahala Capital Management, LLC (2.63M shares), Appian Way Asset Management LP (1.33M shares), Y.D. More Investments Ltd (1.2M shares), Phoenix Holdings Ltd. (1.18M shares), Clal Insurance Enterprises Holdings Ltd (698K shares), VANGUARD GROUP INC (364K shares), GEODE CAPITAL MANAGEMENT, LLC (268K shares), Clarity Capital Partners LLC (205K shares), BANK OF MONTREAL /CAN/ (150K shares), and Royal Bank of Canada (133K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.